by Carolyn Helms | Jun 15, 2021
Xeris Biopharma (NASDAQ: XERS) is a biotechnology company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. 
by Carolyn Helms | May 12, 2021
Alpha-9 Oncology is a biotechnology company developing imaging and therapeutic molecules for the treatment of solid and hematologic cancers. 
by Carolyn Helms | Apr 27, 2021
Theseus Pharmaceuticals is a biotechnology company developing pan-variant tyrosine kinase inhibitors designed to overcome treatment-resistant cancer.
